Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation

Human Gene Therapy Methods

Volumn 23, Issue 4, 2012, Pages 225-233

  Wang, Yuan ^a,b,c   Ling, Chen ^c   Song, Liujiang ^c,d,e   Wang, Lina ^a,b,c   Aslanidi, George V ^c   Tan, Mengqun ^d,e   Ling, Changquan ^a,b   Srivastava, Arun ^c,f,g  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e Shenzhen Institute of Xiangya Biomedicine   (China)

^f UNIVERSITY OF FLORIDA   (United States)

^g Cancer and Genetics Research Complex   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; PRIMER DNA; RECOMBINANT DNA; VIRUS DNA; CAPSID PROTEIN;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; DNA HAIRPIN; DNA HYBRIDIZATION; DNA PACKAGING; DNA PROBE; DNA SEQUENCE; DNA VECTOR; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SELF COMPLEMENTARY ADENO ASSOCIATED VIRUS; SEROTYPE; SLOT BLOT HYBRIDIZATION; SOUTHERN BLOTTING; VIRUS CAPSID; VIRUS GENOME; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS TITRATION; WILD TYPE; CELL STRAIN HEK293; CHEMISTRY; GENE VECTOR; GENETICS; METABOLISM; MUTATION; NUCLEIC ACID HYBRIDIZATION; SEROTYPING; VIRUS ASSEMBLY;

BLOTTING, SOUTHERN; CAPSID; CAPSID PROTEINS; DEPENDOVIRUS; DNA PRIMERS; DNA, VIRAL; GENETIC VECTORS; GENOME, VIRAL; HEK293 CELLS; HUMANS; MUTATION; NUCLEIC ACID HYBRIDIZATION; REAL-TIME POLYMERASE CHAIN REACTION; SEROTYPING; VIRUS ASSEMBLY;

EID: 84872233239     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.090     Document Type: Article

References (44)

1. Agbandje-McKenna, M., and Kleinschmidt, J. (2011). AAV capsid structure and cell interactions. Methods Mol. Biol. 807, 47-92.
2. Allay, J.A., Sleep, S., Long, S., et al. (2011). Good manufacturing practice production of self-complementary serotype 8 adenoassociated viral vector for a hemophilia B clinical trial. Hum. Gene Ther. 22, 595-604.
3. Aslanidi, G.V., Rivers, A.E., Ortiz, L., et al. (2012) High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. Vaccine 30, 3908-3917.
4. Aurnhammer, C., Haase, M., Muether, N., et al. (2012). Universal real-time PCR for the detection of and quantification of adenoassociated virus serotype 2-derived inverted terminal repeat sequences. Hum. Gene Ther. 23, 18-28.
5. Chen, T.T., Rakheja, D., Hung, J.Y., et al. (2009). Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. Pediatr. Blood Cancer 53, 1040-1047.
6. Cheng, B., Ling, C., Dai, Y., et al. (2012). Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells. Gene Ther. 19, 375-384.
7. Clark, K.R., Liu, X., McGrath, J.P., and Johnson, P.R. (1999). Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wildtype viruses. Hum. Gene Ther. 10, 1031-1039. (Pubitemid 29195432)
8. Dong, B., Nakai, H., and Xiao, W. (2010). Characterization of genome integrity for oversized recombinant AAV vector. Mol. Ther. 18, 87-92.
9. Douar, A.M., Poulard, K., Stockholm, D., and Danos, O. (2001). Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75, 1824-1833. (Pubitemid 32110172)
10. Duan, D., Yue, Y., Yan, Z., et al. (2000). Endosomal processing limits gene transfer to polarized airway epithelia by adenoassociated virus. J. Clin. Invest. 105, 1573-1587. (Pubitemid 30390308)
11. Fagone, P., Wright, J.F., Nathwani, A.C., et al. (2012). Systemic errors in quantitative polymerase chain reaction titration of selfcomplementary adeno-associated viral vectors and improved alternative methods. Hum. Gene Ther. Methods 23, 1-7.
12. Glushakova, L.G., Lisankie, M.J., Eruslanov, E.B., et al. (2009). AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Mol. Genet. Metab. 98, 289-299.
13. Gray, S.J., Choi, V.W., Asokan, A., et al. (2011). Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Curr. Protoc. Neurosci. Chapter 4, Unit 4 17.
14. Grieger, J.C., and Samulski, R.J. (2005). Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J. Virol. 79, 9933-9944. (Pubitemid 41022335)
15. Halbert, C.L., Standaert, T.A., Aitken, M.L., et al. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol. 71, 5932-5941. (Pubitemid 27304930)
16. Kapranov, P., Chen, L., Dederich, D., et al. (2012). Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum. Gene Ther. 23, 46-55.
17. Kauss, M.A., Smith, L.J., Zhong, L., et al. (2010). Enhanced longterm transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2. Hum. Gene Ther. 21, 1129-1136.
18. Kube, D.M., and Srivastava, A. (1997). Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Res. 25, 3375-3376. (Pubitemid 27338702)
19. Lai, Y., Yue, Y., and Duan, D. (2010). Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome or = 8.2 kb. Mol. Ther. 18, 75-79.
20. Li, W., Asokan, A., Wu, Z., et al. (2008). Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol. Ther. 16, 1252-1260. (Pubitemid 351866056)
21. Ling, C., Lu, Y., Kalsi, J.K., et al. (2010). Human hepatocyte growth factor receptor is a cellular coreceptor for adenoassociated virus serotype 3. Hum. Gene Ther. 21, 1741-1747.
22. Ling, C., Lu, Y., Cheng, B., et al. (2011). High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors. J. Vis. Exp. pii: 2538. doi: 10.3791/2538.
23. Lock, M., Alvira, M., Vandenberghe, L.H., et al. (2010). Rapid, simple, and versatile manufacturing of recombinant adenoassociated viral vectors at scale. Hum. Gene Ther. 21, 1259-1271.
24. Maheshri, N., Koerber, J.T., Kaspar, B.K., and Schaffer, D.V. (2006). Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24, 198-204. (Pubitemid 43221704)
25. Markusic, D.M., Herzog, R.W., Aslanidi, G.V., et al. (2010). Highefficiency transduction and correction of murine hemophilia b using AAV2 vectors devoid of multiple surface-exposed tyrosines. Mol. Ther. 18, 2048-2056.
26. Mingozzi, F., and High, K.A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12, 341-355.
27. Monahan, P.E., Lothrop, C.D., Sun, J., et al. (2010). Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol. Ther. 18, 1907-1916.
28. Nakabayashi, H., Taketa, K., Miyano, K., et al. (1982). Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858-3863. (Pubitemid 12054507)
29. Nathwani, A.C., Rosales, C., McIntosh, J., et al. (2011). Long-term safety and efficacy following systemic administration of a selfcomplementary AAV vector encoding human fix pseudotyped with serotype 5 and 8 capsid proteins. Mol. Ther. 19, 876-885.
30. Petrs-Silva, H., Dinculescu, A., Li, Q., et al. (2011). Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol. Ther. 19, 293-301.
31. Ponder, K.P. (2011). Hemophilia gene therapy: a Holy Grail found. Mol. Ther. 19, 427-428.
32. Qiao, C., Zhang, W., Yuan, Z., et al. (2010). Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Hum. Gene Ther. 21, 1343-1348.
33. Reed, S.E., Staley, E.M., Mayginnes, J.P., et al. (2006). Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adenoassociated virus vectors. J. Virol. Methods 138, 85-98. (Pubitemid 44633451)
34. Samulski, R.J., Chang, L.S., and Shenk, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822-3828. (Pubitemid 19205454)
35. Sarkar, R., Tetreault, R., Gao, G., et al. (2004). Total correction of hemophilia a mice with canine FVIII using an AAV8 serotype. Blood 103, 1253-1260. (Pubitemid 38168635)
36. Sommer, J.M., Smith, P.H., Parthasarathy, S., et al. (2003). Quantification of adeno-associated virus particles and empty capsids by optical density measurement. Mol. Ther. 7, 122-128. (Pubitemid 36305364)
37. Sonntag, F., Schmidt, K., and Kleinschmidt, J.A. (2010). A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl. Acad. Sci. U. S. A. 107, 10220-10225.
38. Sonntag, F., Kother, K., Schmidt, K., et al. (2011). The assemblyactivating protein promotes capsid assembly of different adeno-associated virus serotypes. J. Virol. 85, 12686-12697.
39. Southern, E.M., (1975). Detection of specific sequences, among DNA fragments seperated by gel electrophoresis. J. Mol. Biol. 98, 503-517.
40. Wu, J., Zhao, W., Zhong, L., et al. (2007). Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum. Gene Ther. 18, 171-182. (Pubitemid 46446054)
41. Wu, Z., Yang, H., and Colosi, P. (2010). Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80-86.
42. Yan, Z., Zak, R., Luxton, G.W., et al. (2002). Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76, 2043-2053. (Pubitemid 34150672)
43. Zhong, L., Zhao, W., Wu, J., et al. (2007). A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis. Mol. Ther. 15, 1323-1330. (Pubitemid 46965329)
44. Zhong, L., Li, B., Mah, C.S., et al. (2008). Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. U. S. A. 105, 7827-7832. (Pubitemid 351872723)